Abnormal intestinal permeability in Crohn's disease pathogenesis

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 159-165

  Teshima, Christopher W ^a   Dieleman, Levinus A ^a   Meddings, Jon B ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Crohn's disease; Experimental colitis; Intestinal permeability; Microbiome; Pathogenesis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADAPTIVE IMMUNITY; ARTICLE; CROHN DISEASE; ENTERITIS; GENE MUTATION; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PATHOGENESIS; SMALL INTESTINE;

RODENTIA;

EID: 84862901476     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06612.x     Document Type: Article

References (54)

1. Salim, S.Y. & J.D. Söderholm 2011. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel Dis. 1: 362-381.
2. Arrieta, M.C., L. Bistritz & J.B. Meddings 2006. Alterations in intestinal permeability. Gut 5: 1512-1520.
3. Teshima, C.W. & J.B. Meddings 2008. The measurement and clinical significance of intestinal permeability. Curr. Gastroenterol. Rep. 1: 443-449.
4. Meddings, J.B. & I. Gibbons 1998. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 11: 83-92.
5. Meddings, J.B., L.R. Sutherland, N.I. Byles, et al 1993. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 10: 1619-1626.
6. Fihn, B.M., A. Sjöqvist & M. Jodal 2000. Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport. Gastroenterology 11: 1029-1036.
7. Jenkins, R.T., D.B. Jones, R.L. Goodacre, et al 1987. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am. J. Gastroenterol. 8: 1159-1164.
8. Jenkins, R.T., J.K. Ramage, D.B. Jones, et al 1988. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. Clin. Invest. Med. 1: 151-155.
9. Pironi, L., M. Miglioli, E. Ruggeri, et al 1990. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease. Dig. Dis. Sci. 3: 582-588.
10. Adenis, A., J.F. Colombel, P. Lecouffe, et al 1992. Increased pulmonary and intestinal permeability in Crohn's disease. Gut 3: 678-682.
11. Wyatt, J., G. Oberhuber, S. Pongratz, et al 1997. Increased gastric and intestinal permeability in patients with Crohn's disease. Am. J. Gastroenterol. 9: 1891-1896.
12. Sanderson, I.R., P. Boulton, I. Menzies, et al 1987. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 2: 1073-1076.
13. Suenaert, P., V. Bulteel, L. Lemmens, et al 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 9: 2000-2004.
14. Wyatt, J., H. Vogelsang, W. Hübl, et al 1993. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 34: 1437-1439.
15. Hilsden, R.J., J.B. Meddings, J. Hardin, et al 1999. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm. Bowel Dis. 5: 85-91.
16. D'Incà, R., V. Di Leo, G. Corrao, et al 1999. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am. J. Gastroenterol. 9: 2956-2960.
17. Arnott, I.D., K. Kingstone & S. Ghosh 2000. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand. J. Gastroenterol. 3: 1163-1169.
18. Tibble, J.A., G. Sigthorsson, S. Bridger, et al 2000. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 11: 15-22.
19. Zeissig, S., N. Bürgel, D. Günzel, et al 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 5: 61-72.
20. Schulzke, J.D., S. Ploeger, M. Amasheh, et al 2009. Epithelial tight junctions in intestinal inflammation. Ann. N. Y. Acad. Sci. 116: 294-300.
21. Hollander, D., C.M. Vadheim, E. Brettholz, et al 1986. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 10: 883-885.
22. May, G.R., L.R. Sutherland & J.B. Meddings 1993. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 10: 1627-1632.
23. Peeters, M., B Geypens, D. Claus, et al 1997. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 11: 802-807.
24. Secondulfo, M., L. de Magistris, R. Fiandra, et al 2001. Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig. Liver Dis. 3: 680-685.
25. Fries, W., M.C. Renda, M.A. Lo Presti, et al 2005. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. Gastroenterol. 10: 2730-2736.
26. Orholm, M., P. Munkholm, E. Langholz, et al 1991. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 32: 84-88.
27. Monsén, U., O. Bernell, C. Johansson, et al 1991. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand. J. Gastroenterol. 2: 302-306.
28. Fielding, J.F. 1986. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J. Clin. Gastroenterol. 8: 655-657.
29. D'Incà, R., V. Annese, V. Di Leo, et al 2006. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment. Pharmacol. Ther. 2: 1455-1461.
30. Irvine, E.J. & J.K. Marshall 2000. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 11: 1740-1744.
31. Khor, B., A. Gardet & R.J. Xavier 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 47: 307-317.
32. Buhner, S., C. Buning, J. Genschel, et al 2006. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 5: 342-347.
33. Meddings, J. 2008. What role does intestinal permeability have in IBD pathogenesis? Inflamm. Bowel Dis. 14: S138-S139.
34. Arrieta, M.C., K. Madsen, J. Doyle, et al 2009. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 5: 41-48.
35. Olson, T.S., B.K. Reuter, K.G.E. Scott, et al 2006. The primary defect in experimental ileitis originates from a nonhematopoietic source. J. Exp. Med. 20: 541-552.
36. Macdonald, T.T., I. Monteleone, M.C. Fantini, et al 2011. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 14: 1768-1775.
37. Maloy, K.J. & F. Powrie 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 47: 298-306.
38. Santaolalla, R. & M.T. Abreu 2012. Innate immunity in the small intestine. Curr. Opin. Gastroenterol. 2: 124-129.
39. Shaw, M.H., N. Kamada, N. Warner, et al 2011. The ever-expanding function of NOD: autophagy, viral recognition, and T cell activation. Trends Immunol. 3: 73-79.
40. Hisamatsu, T., M. Suzuki, H.C. Reinecker, et al 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 12: 993-1000.
41. Wehkamp, J., J. Harder, M. Weichenthal, et al 2004. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 5: 1658-1664.
42. Wehkamp, J., N.H. Salzman, E. Porter, et al 2005. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 10: 18129-18134.
43. Cooney, R., J. Baker, O. Brain, et al 2010. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 1: 90-97.
44. Travassos, L.H., L.A.M. Carneiro, M. Ramjeet, et al 2010. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 1: 55-62.
45. Rehman, A., C. Sina, O. Gavrilova, et al 2011. Nod2 is essential for temporal development of intestinal microbial communities. Gut 6: 1354-1362.
46. Halfvarson, J., L. Bodin, C. Tysk, et al 2003. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 12: 1767-1773.
47. Thjodleifsson, B., G. Sigthorsson, N. Cariglia, et al 2003. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 12: 1728-1737.
48. Pham, M., S.T. Leach, D.A. Lemberg, et al 2010. Subclinical intestinal inflammation in siblings of children with Crohn's disease. Dig. Dis. Sci. 5: 3502-3507.
49. Nusrat, A., J.R. Turner & J.L. Madara 2000. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 27: G851-G857.
50. Howe, K.L., C. Reardon, A. Wang, et al 2005. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O15:H7-induced increased permeability. Am. J. Pathol. 16: 1587-1597.
51. Utech, M., M. Brüwer & A. Nusrat 2006. Tight junctions and cell-cell interactions. Methods Mol. Biol. 34: 185-195.
52. Zeissig, S., C. Bojarski, N. Buergel, et al 2004. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 5: 1295-1302.
53. Hilsden, R.J., J.B. Meddings & L.R. Sutherland 1996. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 11: 1395-1403.
54. Suenaert, P., V. Bulteel, S. Vermeire, et al 2005. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent. Inflamm. Bowel Dis. 1: 667-673.